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Amyloid beta (Ab) peptide aggregation is linked to the initiation of Alzheimer’s disease; accordingly,
aggregation-prone isoforms of Ab, expressed in the brain, shorten the lifespan of Drosophila mela-
nogaster. However, the lethal effects of Ab are not apparent until after day 15. We used shibireTS ﬂies that
exhibit a temperature-sensitive paralysis phenotype as a reporter of proteostatic robustness. In this
model, we found that increasing age but not Ab expression lowered the ﬂies’ permissive temperature,
suggesting that Ab did not exert its lethal effects by proteostatic disruption. Instead, we observed that
chemical challenges, in particular oxidative stressors, discriminated clearly between young (robust) and
old (sensitive) ﬂies. Using nuclear magnetic resonance spectroscopy in combination with multivariate
analysis, we compared water-soluble metabolite proﬁles at various ages in ﬂies expressing Ab in their
brains. We observed 2 genotype-linked metabolomic signals, the ﬁrst reported the presence of any Ab
isoform and the second the effects of the lethal Arctic Ab. Lethality was speciﬁcally associated with signs
of oxidative respiration dysfunction and oxidative stress.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Many common disorders of the elderly are linked to the depo-
sition of speciﬁc-protein aggregates resulting in damage to neuro-
logic, vascular, and endocrine tissues. The incidence of these
conditions increases approximately exponentially with age, and
consequently, the underlying mechanisms have become the focus
of much research (Morimoto, 2008; Taylor and Dillin, 2011). Some
of the common pathologic protein aggregates include plaques
(Hardy and Selkoe, 2002) and tangles (Mandelkow et al., 2007) in
Alzheimer’s disease (AD; Blennow et al., 2006), whereas other
amyloid deposits are associated with disorders such as amyloid
angiopathy (Revesz et al., 2002) and type II diabetes (Moreira,
2012). As the vast majority of these pathologic hallmarks onlyuted equally.
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a common cause is a failure of the organism tomaintain the correct,
native conformation of proteins throughout its life. This concept of
“proteostatic collapse” occurring in midlife is supported by in vivo
data, particularly from experiments conducted with the nematode
worm Caenorhabditis elegans (reviewed in Balch et al., 2008; Taylor
and Dillin, 2011). Studies led by Morimoto and Dillin indicate a
concerted loss of stability of a wide range of proteins during midlife
in the worm; moreover, this destabilization can be accentuated by
the presence of a protein misfolding stressor such as an
aggregation-prone poly-glutamine peptide (Ben-Zvi et al., 2009;
Gidalevitz et al., 2006).
The underlying mechanisms behind this proteostatic collapse
are insufﬁciently understood. There is evidence for the involvement
of genetically regulated responses to, for example, calorie restric-
tion (Kenyon et al., 1993) and heat shock (Morimoto, 1993); how-
ever, several other factors may also play a key part in this process.
Among these, the role of oxidative stress and age-related metabolic
changes may be of particular importance (Finkel and Holbrook,
2000; Houtkooper et al., 2011). It is not clear whether proteo-
static collapse causes metabolic changes or vice versa. However,
there is strong biochemical evidence showing that long-lived
proteins undergo oxidative and other chemical changes thatunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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and Brunk, 2006). In addition, the incidence of metabolic disor-
ders such as diabetes also correlates with aging and in many pa-
tients diabetes and proteostatic disorders such as AD are both
present (Biessels et al., 2006; Munch et al., 1998).
The importance of metabolic alterations as part of the pathology
of age-related neurodegenerative disorders such as Alzheimer’s has
been supported by an array of studies conducted with mouse
models and clinical samples from patients with AD (reviewed in
Barba et al., 2008; Trushina and Mielke, 2013). Some plausible
biomarkers of AD include n-acetylaspartate that reports neuronal
loss and myo-inositol which is a marker of gliosis and inﬂamma-
tion. A recent lipidomic study has indicated that a panel of 10
metabolic biomarkers is sufﬁcient to allow conﬁdent prediction of
which patients with a mild cognitive impairment will progress to
AD (Mapstone et al., 2014). Such metabolic markers can be used to
detect disease onset and then monitor pathologic progression.
Although the metabolic changes in AD are distinct from normal
aging, it remains unclear whether these changes are the cause or
effect of the associated-protein aggregation pathology.
Deﬁning the processes underpinning the age-related incidence
of AD is of practical importance, as diagnostic assays based on ge-
nomics, proteomics, and metabolomics are all now possible. By
understanding the initial steps that lead to pathology, we can
identify biomarkers and develop assays that will allow early diag-
nosis and then treatment of age-related disorders. In this study, we
have used a well-characterized Drosophila model (Crowther et al.,
2005) as a tool to extend our understanding of how proteostatic
deﬁcits and metabolomic changes may lead to the age-related
toxicity of the amyloid beta (Ab) peptide (Rogers et al., 2012).
2. Methods
2.1. Fly stocks
Drosophila cultures were maintained on standard ﬂy medium
containing 1.25% (w/v) agar, 10.5% (w/v) dextrose, 10.5% (w/v)
maize, and 2.1% (w/v) yeast that were supplemented with a
fungicide (methylparaben) and sparse grains of dried yeast on the
surface. Fly cultures were maintained in bottles and vials at 18 C,
25 C, or 29 C according to standard Drosophila husbandry tech-
niques (Ashburner et al., 2005). Experiments using the inducible
gene switch (GS) driver (Osterwalder et al., 2001) for inducible Ab
expression were performed with ﬂies carrying 2 transgenes for
Ab42. This stock has been characterized previously (Luheshi et al.,
2007). Unless otherwise stated, all other experiments were car-
ried out with single transgenic Ab40, Ab42, and Arctic Ab42 ﬂies
which have been described previously (Kruppa et al., 2013). The Ab
transgene was inserted into the 51D location on the second chro-
mosome using the 4C31 integrase system (Bischof et al., 2007).
Temperature titration experiments to measure the protein ho-
meostasis were performed with Drosophila shibireTS2 constructs,
which have been described earlier (Grigliatti et al., 1973).
2.2. Longevity assays with constitutive Ab expression
Longevity assays were conducted as described previously
(Crowther et al., 2005). Drosophila stocks carrying various UAS-Ab
isoforms were crossed with the elavc155-Gal4 promoter stock to
induce pan-neuronal transgene expression in the offspring.
Longevity experiments were performed on populations of 90e100
mated females, sorted into groups of 10. The statistical interpreta-
tion of longevity data was conservative: we considered the median
survival values for each of the 9e10 subgroups of ﬂies per condition
as estimates of the population mean. According to, the Wilcoxon-rank test was used to determine whether the median survivals of
the population pairs were signiﬁcantly different from each other.
When estimating mortality trajectories; a minimum of 150 ﬂies per
genotype were assessed. Mortality trajectories were generated by
plotting the natural log of the chance of dying over the coming
24 hours versus the age of the ﬂies. The ﬁrst and last 5% of all
recorded death events were excluded to minimize noise as
described previously (Shaw et al., 1999).
2.2.1. Longevity assays with inducible Ab expression
The mifepristone (RU 486, Sigma-Aldrich) inducing agent was
dissolved at 10 mg/mL in ethanol and further diluted in sterile
water to its ﬁnal concentration. Vials of ﬂy food were treated with
300 mL of the drug solution, or vehicle, and left to air dry for 2 days
at room temperature (25 C) before use. The food was used within
4 days of preparation or else discarded. To achieve inducible,
pan-neuronal, expression of Ab with the GS system, Drosophila
homozygous for the Ab42 transgene on the second and third chro-
mosomes (Ab42.3; Ab42.4, as previously described in [Crowther et al.,
2005]) were ﬁrst crossed with the GS-elav-Gal4 driver line and the
offspring treated with 200 mg/mL of RU 486. In other respects,
longevity assays using drug-inducible Ab expression (Osterwalder
et al., 2001), were identical to the protocol for constitutive Ab
expression as described previously (Crowther et al., 2005).
2.2.2. Temperature titration locomotion assays with Drosophila
shibireTS2 mutants
The effect of Ab expression on the shibireTS2-mediated paralytic
phenotype was assessed for ﬂies of various ages. UAS-Ab stocks were
crossed with ﬂies carrying the constitutive pan-neuronal elav-Gal4
driver (chromosome 3). Male offspring carrying both transgenes,
over balancer chromosomes, were mated with females homozygous
for the shibireTS2 allele (X chromosome). The walking velocities of
male offspring carrying shibireTS2  Ab expression were recorded by
using the iFly tracking system described previously (Jahn et al., 2011).
The climbing velocity of 30 male ﬂies, in 3 groups of 10 was assessed
in triplicate for each genotype at day 5, 15, and 35 after eclosion. All
Drosophila shibireTS2 mutants were maintained and aged at the
permissive temperature of 18 C. Before each measurement, the ﬂies
were incubated for 90 seconds in preheated glass vials in a water
bath at required temperature. Differences in climbing performance
between genotypes were probed for statistical signiﬁcance by a 2-
way analysis of variance (ANOVA) using the GraphPad Prism statis-
tical package (Graph Pad Prism Software, Inc.).
2.3. Hydrogen peroxide lethality assays
Mated female ﬂies were sorted into at least 8 groups of 20 and
cultured at 25 C throughout the experiment. The control popula-
tion was maintained on 2% (w/v) agar containing 5% (w/v) sucrose.
The food was supplemented with 10% (v/v) hydrogen peroxide for
the test population. Survival rates 72 hours postexposure were
tabulated. The statistical signiﬁcance of mortality differences be-
tween genotypes throughout aging was assessed by a 2-way
ANOVA.
2.4. Brain dissections
Brain dissections were performed as described previously (Costa
et al., 2011).
2.5. Quantitative polymerase chain reaction
Quantitative polymerase chain reaction for Ab mRNA was car-
ried out as described previously (Kruppa et al., 2013).
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The procedure has been described elsewhere (Luheshi et al.,
2010). For the quantiﬁcation of total Ab levels, heads from 10 ﬂies
were collected and homogenized in 20 mL 5 M guanidine hydro-
chloride (GnHCl; Melford Laboratories, UK) extraction buffer (1x
stock: 50 mMHepes pH 7.3, 5 mM ethylenediaminetetraacetic acid,
and 5 M GnHCl) manually for 1 minute. The samples were then
sonicated in a water bath at room temperature for 480 seconds and
centrifuged for 7 minutes at 18,000 g. Five mL of supernatant were
diluted down 1:5 in a Meso Scale Discovery (MSD) dilution buffer
(50 mMHepes pH 7.3, 10 mM ethylenediaminetetraacetic acid, 0.1%
(w/v) MSD Blocker A [bovine serum albumin in a phosphate
buffered saline (PBS)-based buffer]; MSD, USA). Each 96 well
Avidin or Streptavidin plate (MSD, USA) was precoated with 3% (w/
v) MSD-Blocker A in PBS either for 1 hour at room temperature on a
shaker or overnight at 4 C. Between each of the next steps, the
plate was washed with 0.05% (v/v) PBS-Tween. Samples were
incubated for 1 hour at room temperature with the biotinylated
6E10 (Cambridge Biosciences, UK) primary antibody (epitope
located within the 3-8 N-terminal amino acids of Ab), followed by
1.5 hours of incubation with the calibration and test samples in the
various wells (the standard curve mixture, water, and the
Drosophila samples). At last, 1 hour incubation at room temperature
with the sulpho-tagged 21F12 secondary antibody (epitope located
within the 33-42 C-terminal amino acids of Ab, Elan Pharmaceu-
ticals, USA) was performed. The plate was read on an MSD-plate
reader (MSD, USA) according to the manufacturer’s instructions.
For measuring soluble Ab 1% (w/v) sodium dodecyl sulfate (SDS) in
PBS buffer was used for the initial extraction instead of 5 M GnHCl.
The remaining steps of the protocol were identical except for the
centrifugation step: a 7 seconds pulse spin was used instead, to
ensure the peptide remained in the supernatant. The standard
curve for the assay was constructed using the SDS-extraction pro-
tocol and was used to estimate concentrations for both SDS-soluble
and total Ab assays; this may result in signiﬁcant underestimation
of total Ab levels because of GnHCl interference in the latter assay.
Differences in Ab concentrations between samples were probed by
the Student’s t-test and the ANOVA Bonferroni test.
2.7. 1H-Nuclear magnetic resonance (NMR) spectroscopy
To induce pan-neuronal expression of Ab in the progeny, UAS-
Ab40, UAS-Ab42, and UAS-Ab42 Arctic stocks were crossed with the
elavc155-Gal4 promoter. To control for metabolic changes in the
absence of Ab expression, elavc155 ﬂies were crossed with a stock
containing the empty 51D insertion site. Subsequently, the progeny
of this stock are referred to as “51D control” in the text. The offspring
with thedesiredgenotypewereagedat 29 Cbeforeharvesting. Flies
were collected according to a computer-generated random scheme
that avoided any time-of-day or position-in-cohort artefacts. Once
collected, the ﬂies were frozen in liquid nitrogen and decapitated by
vortexing while frozen. Fly heads and bodies were homogenized
separately in 350 mL of ice-cold 50% (v/v) acetonitrile (Merck,
Germany) in distilled water solution by using an electric homoge-
nizer. The samples were then centrifuged for 20minutes at 18,000 g
(Minispin centrifuge; Eppendorf, Germany) at 4 C, and the super-
natantwas transferred into a newmicrocentrifuge tube, lyophilized,
and stored at80 C. Each sample consisted of either 50 ﬂy heads or
bodies. The experiment was performed in triplicate per condition.
Before NMR analysis, the samples were rehydrated in 650 mL of
50mMphosphatebuffer inD2O (pH7.4) supplementedwith50mg/L
3-trimethylsilyl propionic acidD4 (TSP) as a chemical shift reference,
and 50 mg/L sodium azide to avoid bacterial growth. Subsequently,
600 mL of the rehydrated samplewere transferred into a 5-mmNMRtube. The NMRmeasurements were carried out at 25 C on a Bruker
Avance-III 600 spectrometer (Bruker Biospin, Germany) which was
equipped with a double-tuned 1H-13 C cryoprobe and operated at a
1H frequency of 600.13 MHz. The 1H NMR spectra were acquired
using a single 90 pulse experimentwith a Carr PurcellMeiboomGill
delay added, to attenuate broad signals from highmolecular weight
components. The total Carr Purcell Meiboom Gill delay was 40 ms
and the spin echo delay 200 ms. The water signal was suppressed by
presaturation of the water peak during the relaxation delay of
4 seconds. A total of 98,304 data points spanning a spectral width of
24 ppm were collected in 64 and 128 transients for ﬂy bodies and
heads, respectively. For assignment purposes, 2-dimensional 1H-1H
COSY, 1H-1H TOCSY, 1H-13 C HSQC, 1H-13 C HSQC-TOCSY, and 1H-13 C
HMBC spectra were acquired. The spectra were processed using
iNMR(www.inmr.net). An exponential linebroadeningof 0.5Hzwas
applied to the free induction decay, before Fourier transformation.
All spectra were referenced to the TSP signal at 0.017 ppm, auto-
matically phased and baseline corrected. The spectra were aligned
using Icoshift (Savorani et al., 2010), and the region around the re-
sidual water signal (4.88e4.67 ppm) was removed. Moreover, the
high- and low-ﬁeld ends of the spectrum, where no signals except
the reference signal from TSP appeared, were also removed (i.e.,
leaving data between 9.5 and 0.5 ppm). The integrals were
normalized to total intensity to suppress trivial separation based on
variations in sample amount, and the data were scaled using pareto
scaling (Craig et al., 2006) and centered.
2.7.1. NMR data analysis
Initially, the whole data set was subjected to principal compo-
nent analysis (PCA) (Stoyanova and Brown, 2001). Afterward,
orthogonal projection to latent structures discriminant analysis
(OPLS-DA) models were created to separate the following 3 classes
of ﬂy populations: (1) control ﬂies, (2) Ab42 expressing ﬂies that
showed a minimal decrease in longevity under the tested condi-
tions, and (3) Arctic Ab42 ﬂies which showed a signiﬁcant decrease
in median survival in a longevity assessment that was run in par-
allel. OPLS-DA models are multivariate models that predict group
membership based on a multivariate input, in this case the NMR
spectra. The model separates variations because of group mem-
bership from other (orthogonal) variations (Trygg andWold, 2003).
The models were constructed by using the spectral data of 18- and
21-day-old ﬂies and were then implemented to predict the class
and age for all other ﬂies. To identify metabolites that responded to
nontoxic Ab expression, we constructed OPLS-DA models using
data from 14- to 24-day-old 51D controls that do not express Ab,
and compared them to Ab40 and Ab42 ﬂies where Ab expressionwas
largely nontoxic. Similarly, to probe for metabolites associated with
Ab toxicity, we compared proﬁles of Ab40 and Ab42 ﬂies with those
from ﬂies expressing the lethal Arctic Ab42. The loadings and the
correlation coefﬁcient (R) between intensities at the individual
frequencies and the predictive component were calculated. A cutoff
value for R2 corresponding to p < 0.01 with Bonferroni correction
for an assumed number of 100 metabolites was calculated from
the distribution of R2 values in 10,000 permutated data sets.
Xanthurenic acid was conﬁrmed by spiking. The remaining
assignments were done based on chemical shifts only, using earlier
assignments, and spectral databases described elsewhere (Cui et al.,
2008; Malmendal et al., 2006; Pedersen et al., 2008) and compar-
ison with Drosophila metabolites identiﬁed by mass spectrometry
(Chintapalli et al., 2013). OPLS models predict the value of a
continuous variable based on a multivariate input (Trygg andWold,
2002). OPLS models for age were built using 14 to 40-day-old
control and Ab42 ﬂies. These models were used to predict the
“metabolomic age” of samples for Ab40 and Arctic Ab42 expressing
Drosophila. All multivariate analysis was performed using the
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both ﬂy heads and bodies.
3. Results
3.1. Aging increases the sensitivity of Drosophila to the toxic effects
of Ab
The toxicity of Ab peptides in our Drosophila model system is
dependent on both the aggregation propensity of each isoform and
the intensity of its expression.When cultured at 25 C, ﬂies carrying
Ab40 and Ab42 transgenes inserted at the 51D genomic locus and
driven by elavc155-Gal4 exhibit no reduction in longevity (Fig. 1A)
and do not show Ab deposition (Supplementary Fig. 1). By contrast,
ﬂies expressing the aggregation prone Arctic (E22 G) variant
(Nilsberth et al., 2001) of Ab42 under the same conditions have a
shorter lifespan and display Ab deposits in the brain (Fig. 1A and
Supplementary Fig. 1). These ﬂy lines have been extensively char-
acterized, and the transgenes have been shown to express mRNA at
equivalent levels (Crowther et al., 2005). Moreover, we also
conﬁrmed that Ab-mRNA levels did not change signiﬁcantly
throughout life (Supplementary Fig. 2).
When we calculated the mortality trajectories (logarithm of the
daily probability of death), we found that the 51D control, Ab40 and
Ab42 lines followed the same linear trajectory, reﬂecting the ex-
pected exponential increase in the likelihood of death with age. The
equivalent trajectory for Arctic Ab42 ﬂies was also linear but was
steeper, indicating that the age-related probability of death in these
ﬂies was rising more rapidly than for ﬂies expressing Ab40 and Ab42.
Remarkably, when the linear ﬁts were extrapolated back in time,
the Arctic Ab42 ﬂies did not diverge from the other lines until a point
in midadult life around day 15 (Fig. 1B).
Thus, young ﬂies (<15 days) appeared more robust and showed
less marked increases in the likelihood of death in the presence of
Ab isoforms that are otherwise lethal when present later in life. To
investigate this observation directly, we set up a series of ﬂies that
carried two Ab42 transgenes under the control of an inducible
promoter. Our initial experiments examined the longevity effects of
15-daywindows of Ab induction, speciﬁcally days 0e15,10e25, and
20e35 (Fig. 2A). Here, we did not observe any substantial re-
ductions in longevitywhen Ab expressionwas triggered only before
day 15. However, when Ab expression was induced after this age,
we recorded signiﬁcant reductions in lifespan.
A subsequent experiment compared the survival of 4 groups of
Drosophila: (1) where Ab expression was never induced, (2) where
Abwas continuously induced, (3) where Ab expressionwas inducedFig. 1. The expression of Ab42 Arctic but not Ab42 or Ab40 reduces median survival. (A) Pan
compared to the 51D control population that does not express Ab. The Arctic isoform of A
survivals were assessed by the ManneWhitney test (*** p < 0.001, error bars show the standa
linear mortality trajectory for ﬂies expressing Arctic Ab42 appears to diverge from ﬂies expr
25 C with at least 15 groups of 10 ﬂies. Abbreviation: Ab, amyloid beta.from hatching until day 15, and (4) where Abwas induced only after
day 15 (Fig. 2B). To ensure that the levels of expressed Ab were
similar for all groups, we undertook a series of experiments in
parallel to calibrate the induction of Ab expression for all conditions
(Supplementary Fig. 3). Whenwe examined themedian survivals of
the groups we observed that, as expected, ﬂies exposed to contin-
uous Ab induction had a shorter lifespan than those in which Ab
expression was never induced. Interestingly, restricting the
expression of Ab to midadult life and later (after day 15) resulted in
a median survival that was essentially identical to the median
survival of ﬂies where Abwas expressed continuously. On the other
hand, when Abwas expressed only up to day 15, the lifespan of ﬂies
was similar to controls with no Ab induction at all. Taken together,
these survival data support the hypothesis that older ﬂies are more
sensitive to the lethal effects of Ab expression as compared with
younger ﬂies.
Usingmortality trajectory analysis, wewere able to estimate this
relative robustness of young ﬂies. Speciﬁcally, in Fig. 2C the ﬁlled
squares represent the mortality of ﬂies with continuous Ab
expression; by comparison the open squares represent ﬂies that are
identical except that they did not experience Ab expression from
days 0e15. These traces are essentially parallel and are separated on
average by a mortality displacement of 1.2. Assuming that this
relative displacement accrued linearly over days 0e15 this corre-
sponds to an Ab-induced increase in the gradient of the mortality
curve of 0.08 day1 (standard error of mean: 9  103 day1; see
Supplementary Table 1A). For ﬁlled circles, the only Ab expression is
fromdays 0 to 15, and these are comparedwith empty circles where
Abwas never expressed.Where paired data points are available, the
average mortality displacement between these traces is 0.7,
resulting in a calculated daily rate of mortality increase of
0.05 day1 (standard error of mean: 8  103 day1) over days
0e15. The average of these 2 estimates of the Ab-attributable in-
crease in the mortality trajectory gradient between days 0e15 is
0.06 day1.
By contrast, the daily increase in mortality that is attributable to
Ab expression in mature adults can be quantiﬁed directly by
comparing the gradients of the following paired traces: ﬁlled
squares versus ﬁlled circles (difference in gradients 0.10 day1) and
empty squares versus empty circles (difference in gradients
0.09 day1; see Supplementary Table 1B). The average of these 2
estimates of the Ab-attributable increase in the mortality trajectory
gradient days 15þ is 0.10 day1. This allows us to estimate that the
Ab-attributable increase in the mortality trajectory gradient is
approximately 50% greater in older adult ﬂies (days 45e85), as
compared with young adults (days 0e15).-neuronal expression of Ab40 or Ab42 did not decrease the median survival of ﬂies as
b42 was toxic and approximately halved the median survival. Differences in median
rd deviation). (B) A plot of the natural log of the daily chance of dying indicates that the
essing other A isoforms at approximately day 15. These experiments were conducted at
Fig. 2. Young ﬂies are resistant to the toxic effects of Ab expression. (A) Ab42 expression in early adulthood (days 1e15) resulted in minimal reduction in longevity, however, later
windows of expression (days 10e25 and 20e35) resulted in larger, approximately 20-day reductions in median survival. The RU486 induction agent had no effect on the median
survival of control ﬂies (w1118). (B) As compared with control ﬂies (“no A”), where Ab is never induced, continuous expression of Ab reduced longevity. Flies in which Ab expression
were limited to days 1e15 had a lifespan that was comparable with controls, whereas expression of Ab from day 15 onward led to a median survival essentially equivalent to
continuous Ab exposure. Flies were cultured at 25 C in 10 groups of 10 ﬂies. Differences in median survivals were assessed by the ManneWhitney test (* p < 0.05, *** p < 0.001,
error bars show the standard deviation). (C) Mortality trajectory analysis of the ﬂies in B indicate that Ab expression from day 1e15 results in an upward displacement of the
mortality trajectories by between 1.2 (closed vs. open squares) and 0.7 (closed vs. open circles; see also Supplementary Table 1). In adult ﬂies, Ab expression increased the gradient of
the mortality trajectories by between 0.90 day 1 (Fig. 2C, “Ab day 15þ” vs. “no Ab”) and 0.10 day 1 (Fig. 2C, “continuous Ab” vs. “Ab day 1e15”) from day 35 onward. In these
experiments, ﬂies carried 2 transgenes for Ab42. Abbreviations: Ab, amyloid beta; ns, not signiﬁcant.
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Using inducible pan-neuronal Ab expression, we compared the
accumulation of soluble and total peptide in young and aged
Drosophila (Osterwalder et al., 2001). One percent w/v SDS extrac-
tion yielded soluble peptide, and these levels were compared with
total Ab as deﬁned by GnHCl-extracted material. We observed an
initial accumulation of soluble peptide in ﬂies expressing Ab from
days 1e15, which dropped to a base level after the inducing agent
waswithdrawn (Fig. 3, green). Under such circumstances, therewas
little increase in total Ab levels, indicating that the soluble material
was largely cleared. When induction was continued, then soluble
and subsequently insoluble peptide progressively accumulated
(30e40 days, black). Induction of Ab exclusively in the older ﬂies
(red, day 15þ), yielded relatively little soluble material with a
higher proportion accumulating as insoluble deposits rather than
being cleared.3.3. Ab toxicity is not accompanied by a generalized protein
homeostasis collapse
Previous studies, particularly in the nematode worm C. elegans,
have indicated that a concerted loss of protein homeostasis ac-
companies the onset of protein misfolding and amyloid deposition.
It was also shown that additional misfolding stressors can desta-
bilize the proteome (Ben-Zvi et al., 2009; Gidalevitz et al., 2006). To
test whether Ab expression precipitates proteostatic collapse in
Drosophila, we assessed the locomotor behavior of a temperature-
sensitive dynamin variant (shibireTS2) using paralysis as a reporter
of proteome stability (van der Bliek and Meyerowitz, 1991). We
have developed a novel assay in which shibireTS2 ﬂies expressing
various isoforms of Ab, or not, undergo a temperature titration to
determine how sensitive they are to thermal stress (Fig. 4). In all
tested Drosophila, we observed an age-related increase in temper-
ature sensitivity, speciﬁcally the temperature at which the ﬂies
Fig. 3. Accumulation of Ab in ﬂy heads throughout aging. The levels of soluble Ab42 (panel A; extracted with 1% w/v SDS in PBS) and total Ab42 (panel B; extracted with 5 M GnHCl)
were measured as the ﬂies aged. The levels in the absence of Ab42 induction (baseline reading) were compared with ﬂies induced continually (black), for days 1e15 (green) and from
day 15 onward (red). Error bars show the standard deviation of 3 biological replicates. GnHCl interference with the assay may result in under-estimation of total A levels in panel B,
however, comparisons within panel B are valid. Abbreviation: Ab, amyloid beta; SDS, sodium dodecyl sulfate.
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5 Ce19 C at day 35. Similarly, the temperature at which the ﬂies
were all paralyzed was reduced from 28 C at day 5 Ce25 C at
day 35.
These data indicate that the shibireTS2 variant of dynamin be-
comes thermally destabilized as the ﬂies age. However, this effect
was not modiﬁed by Ab-peptide expression, including the Arctic
isoform that is toxic under these conditions (Supplementary Fig. 4).
The failure of Ab expression to modulate the age-related thermal
destabilization of dynamin is consistent with the hypothesis that
accelerated proteostatic collapse is not the primary mechanism of
Ab toxicity in our model system.Fig. 4. Ab coexpression does not exacerbate the age-related heat sensitivity of Drosophila
different ages demonstrated that although Drosophila homozygous for shibireTS2 became p
coexpression of Ab did not exacerbate this paralytic phenotype. The locomotor assessmen
walking velocity was undertaken as described previously (Jahn et al., 2011). A 2-way ANO
genotypes. The ﬂies were crossed and maintained at 18 C before each locomotor assessm
behavior of the oldest day 35 ﬂies. Abbreviations: ANOVA, analysis of variance; Ab, amyloid3.4. Aging and Ab expression predispose Drosophila to oxidative
damage
Age-related changes in metabolism, in particular the gener-
ation of reactive oxygen species, are an alternative factor that
may mediate the increased sensitivity of older ﬂies to Ab toxicity
(Finkel and Holbrook, 2000; Rival et al., 2009). To test this pos-
sibility, we gave an oxidative stressor, in the form of 10% (v/v)
H2O2 in the food, to both young and older ﬂies. At day 2, control
ﬂies and those expressing Ab40 were remarkably resistant to this
insult with few dying after 72 hours of exposure. By contrast, the
young Ab42 expressing ﬂies were more sensitive withshibireTS2. Titration of temperature with climbing performance of shibireTS2 ﬂies at
aralyzed at increasingly lower temperatures as they aged (panels A through to C), the
t was carried out with 3 biological replicates per condition. The video assessment of
VA analysis of the climbing performance did not show any differences between the
ent. The 1x shibireTS2 negative control data (rectangles) for all panels represents the
beta.
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bars). Lethality was even higher for Ab42 Arctic ﬂies. In this re-
gard, the day 2 Ab42 ﬂies resemble older, day 20 ﬂies, which
uniformly exhibit increased sensitivity to H2O2 regardless of Ab
expression (Fig. 5, right bars). Thus, day 2 ﬂies are proteostati-
cally robust but sensitive to oxidative stress when they express
Ab42, putting the biochemical changes pathologically upstream
of proteome dysfunction.3.5. A systematic analysis of the metabolic consequences of Ab
expression in the Drosophila brain
To assess the age-related changes in the metabolome in control
ﬂies and those expressing Ab, we have compared the water-soluble
metabolite levels in tissue extracts by 1H-NMR spectroscopy. Flies
were aged and at speciﬁed times frozen and separated into heads
and bodies so that the local and systemic effects of Ab expression
could be assessed. Our initial approach was to analyze the NMR
spectra using PCA. When we plotted principal component 2 (PC2)
versus PC3 it became apparent that there was an age-related tra-
jectory that all the samples were following (Fig. 6). In almost all
cases, the greatest differences were between days 1 and 8 (open
circles), and these were broadly conserved between genotypes.
Moreover, the expression of any Ab isoform produced a displace-
ment of the trajectories as compared with the scores of 51D control
samples. This indicates the presence of profoundmetabolic changes
around the time of hatching in addition to those that can be
attributed to Ab expression. PC1 reported metabolic changes that
did not correlate with genotype or age and was not analyzed
further. Furthermore, a 2-way multivariate analysis of variance on
all PCs revealed signiﬁcant (p < 11015) differences in theFig. 5. Aging and Ab expression increase the sensitivity of Drosophila to oxidative
stress. Young (day 2) control ﬂies, and those expressing Ab40, were relatively resistant
to 72 hours of hydrogen peroxide treatment. All older ﬂies (day 20) were more sen-
sitive to this oxidative challenge. Remarkably, young ﬂies expressing the aggregation-
prone Ab42 isoforms were as sensitive to oxidative stress as the old ﬂies. No deaths
were observed in the control experiment where the ﬂies were kept on equivalent food
without hydrogen peroxide (data not shown). The statistical signiﬁcance of mortality
differences between genotypes with age was assessed by 2-way ANOVA (* p < 0.05,
** p < 0.01, *** p < 0.001, error bars show the standard deviation). Abbreviations:
ANOVA, analysis of variance; Ab, amyloid beta; ns, not signiﬁcant.age-linked metabolomic proﬁles for 51D controls versus Ab40/Ab42
(controls vs. nontoxic Ab expression) and for Ab40/Ab42 versus
Arctic Ab42 (nontoxic Ab vs. toxic Ab expression), for both bodies
and heads.
3.6. Ab expression induces a distinct metabolite response
After day 14, the ﬂy metabolome becomes less temporally dy-
namic, and so,wecreatedanOPLS-DAmodel implementingdata from
matureﬂies.Thegoalwas todiscriminatemetaboliteproﬁlesbetween
(1)51Dcontrolﬂies (Fig. 7, black)and thoseexpressing, (2)Ab42which
is aggregation prone but remains nontoxic under the experimental
conditions (blue), and (3)ArcticAb42which isbothaggregation-prone
and toxic (red). Accordingly, the model was trained using data from
days 18 to 21 ﬂies only; furthermore data from ﬂies expressing Ab40,
whichhas a low-aggregationpropensityand isnontoxic (green),were
not included. When the model was applied to samples that were not
part of the training data set 3 groupings became apparent. First, we
observed that theexpressionofanyAb isoformresulted ina shift away
from controls along the x-axis; thismay be interpreted as an adaptive
response to aggregation prone peptide expression as this signal is
compatible with normal longevity. Among the Ab-expressing group,
there was an additional separation that was associated with reduced
longevityas seen inArcticAbﬂies (Fig. 7, panelsA andB).Notably,ﬂies
expressing Ab40 were located in the same region as those expressing
Ab42. Incidentally, the oldest (30e40 days) control and Ab42 ﬂies
became more similar to the Ab42 Arctic ﬂies but only in the systemic
metabolome (Fig. 7B).
We also created an OPLS model, linking age to metabolic pro-
ﬁles, based on data from days 14 to 40 control and Ab42 ﬂies. This
model was used to estimate the “metabolic age” of ﬂies expressing
Ab40 and Ab42 Arctic, which were not included in the model. The
predicted ages for these ﬂies corresponded closely to calendar age
except for systemic samples from Ab42 Arctic ﬂies that consistently
appeared to be 5 days older than expected (Supplementary Fig. 5A).
3.7. Metabolic changes are associated with Ab expression and Ab
toxicity
Next, we identiﬁed which key metabolites accounted for the
metabolomic signals that are apparent in Fig. 7. First, we compared
controls with Ab40 and Ab42 ﬂies to determine the Ab-linked
metabolic changes in the absence of a signiﬁcant longevity
phenotype. These ﬂies have successfully adapted to protein aggre-
gation stress and so metabolic changes may represent adaptive
cellular responses. In the presence of Ab40/Ab42, there was a four-
fold increase in maltose (Fig. 8 panels A and B, chemical shifts 5.40,
4.64 ppm inter alia, Fig. 9 panels C and I) and a decrease in tyrosine
(7.18, 6.88 ppm, Fig. 8 panels A and B) in both head and body
samples. In the head extracts, there was a marked increase in
xanthurenic acid (7.53, 7.37, 7.16, and 6.92 ppm Fig. 8B, Fig. 9K) on
Ab40/Ab42 expression.
Second, we compared Ab40 and Ab42 with Arctic Ab42 ﬂies to
identify how the metabolome speciﬁcally reported decompensated
protein aggregation. Flies expressing the toxic Arctic Ab42 isoform
showed a distinct series of metabolic changes when compared with
those expressing Ab40/Ab42. In particular, the levels of gluconic acid
(4.10, 4.01, 3.75 ppm Fig. 8 panels C and D, Fig. 9 panels A and G) and
histidine (7.77, 7.05 ppm Fig. 8 panels C and D, Fig. 9 panels B and H)
were increased in older (14e24 days) Arctic Ab42 expressing ﬂies.
Althoughmaltose levels were still much higher than in control ﬂies,
theywere lower than in Ab40 and Ab42 expressing Drosophila (Fig. 8,
panels C and D, Fig. 9 panels C and I). Speciﬁc changes in ﬂy heads
were higher lactate (1.31 ppm Fig. 8D, Fig. 9J) and lower alanine
(3.77, 1.47 ppm Fig 8D). In ﬂy bodies acetate (1.90 ppm) and fatty
Fig. 6. The expression of Ab causes a shift in the age-related changes in ﬂy metabolomes. The ﬁgure shows score plots for principal components 2 and 3 for all head (A) and body (B)
samples. The metabolomic trajectories are indicated by colored lines (open circles for days 0 and 8; closed circles for days 14, 18, 21, 24, 30, and 40; A42 Arctic ﬂies (red) lived only
until day 26 which is their last sampling point). For clarity, error bars showing the standard deviation are presented for the 51D control ﬂies only. The error bars for all other points
were of a similar magnitude. Abbreviation: Ab, amyloid beta.
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whereas adenosine nucleotides (AXP; 8.52, 8.26, 6.13 ppm) and
phosphocholine levels (4.17, 3.58, 3.21 ppm) were reduced (Figs. 8C
and 9D). In both heads and bodies signals from unidentiﬁed aro-
matic compounds (7.93, 6.93 ppm and 8.03, 7.80, 7.20, 6.90 ppm for
heads and bodies, respectively) appeared in NMR spectra from the
Arctic Ab42 expressing ﬂies (Fig. 9 panels F and L). These signals
could not be unambiguously assigned, but when the chemical shifts
were matched against the human metabolome database (Wishart
et al., 2013), 8 of the 10 best matches were hydroxylated, carbox-
ylated, or chlorinated compounds. As an example, the 1H next to a
hydroxyl substituted carbon typically appears around 6.9 ppm. An
additional signal, which likely corresponds to a methyl or methy-
lene attached to an aromatic ring, appeared at 3.25 ppm.
The concentrations of a number of key metabolites were age
dependent and/or Ab dependent. The compounds that most faith-
fully reported the presence of Ab, irrespective of lethality, include
maltose, in the head and body and xanthurenic acid levels in the ﬂy
head (Fig. 9 panels C, I, and K) spectra. Both of these metabolites
were increased in ﬂies expressing Ab40, Ab42 and Arctic Ab42, as
compared with controls. Metabolomic changes speciﬁcally induced
by the expression of the toxic Arctic Ab42 included age-related in-
creases in gluconic acid, histidine, and the appearance ofFig. 7. O2PLS-DAmodeling reveals 2 independentmetabolomic changes, associatedwith A ex
frommatureﬂies (days 18 and21) to assign the remaining samples into3 groups: (1) controlﬂie
report the age in days of the ﬂies. The cross-validated scores of the 18- and 21-day-old sample
colored lines. Abbreviation: Ab, amyloid beta.unidentiﬁed aromatic compounds in both head and body samples
(Fig. 9 panels A, B, E, F, G, H, and L). Levels of lactate were also higher
in head samples (Fig. 9 panel J), and levels of AXP and phos-
phocholine lower in body samples (Fig. 9 panel D), in Arctic Ab42 as
compared with Ab40/Ab42 ﬂies.
4. Discussion
AD is one of the most pressing age-related disorders facing
society. Aging may be considered as the time-dependent accumu-
lation of deﬁcits in protective functions that result in a multisystem
syndrome deﬁned by increased fragility and propensity to die
(Kirkwood and Austad, 2000; Partridge and Gems, 2002). In many
organisms, this produces a log-linear increase in mortality rates
with time (Curtsinger et al., 1992; Partridge et al., 2005). In some
respects, the gradient of themortality trajectorymay be understood
as the rate of physiological aging with chronological time.
Drosophila aging can be slowed by reducing the ambient temper-
ature and delayed by restricting calorie intake (Mair et al., 2003;
Partridge et al., 2005). One important contributor to increased
age-related fragility is a progressive degradation in the structural
integrity of proteins. Such deﬁcits in proteostatic mechanisms have
been described primarily in C. elegans, but a similar process ispression and lethality. O2PLS-DAmodels were created for head (A) and body (B) samples
s, (2) Ab42expressingﬂies, and (3) ArcticAb42. Thedigits associatedwith eachdata point
s that were used to build the O2PLS-DAmodel are indicated by the area encompassed by
Fig. 8. Summary of NMR spectral changes induced by the expression of A40/Ab42 and Ab42 Arctic. The ﬁgure provides an overview of the metabolomic changes induced by Ab-
expression. Positive and negative signals represent the increases and decreases in metabolite concentrations. Signiﬁcant alterations were color coded from blue to red, with red
representing the highest correlation between metabolite and genotype. Panels A and B compare the spectral changes between the 51D control and Ab40/Ab42 samples (comparing
controls with nontoxic A expression), whereas panels C and D compare the changes between Ab40/Ab42 and Ab42 Arctic ﬂies (comparing non-toxic with toxic-A expression).
Abbreviations: Ab, amyloid beta; NMR, nuclear magnetic resonance.
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misfolding disorders such as Alzheimer’s, Parkinson’s and other,
systemic, amyloid diseases (Chiti and Dobson, 2006; Taylor and
Dillin, 2011).
In this study, we have used our Ab-expressing Drosophila as a
model of AD to probe how protein aggregation may modulate
mortality. We asked the questionwhether a generalized increase in
protein aggregation propensity is a cause or a consequence of the
aging process. Our initial experiments indicated that expression of
the lethal Arctic Ab42 increased the gradient of the mortality tra-
jectory. To our surprise, we observed that extrapolation of the plotsto early life indicated that Arctic ﬂies diverged from the control ﬂies
at a point around day 15 of adult life (Fig. 1B). This implies that
young Drosophila before this time point are robust with respect to
protein misfolding stress and that they becomes susceptible to the
lethal effects of protein aggregation during midadult life. We tested
this hypothesis directly using an inducible version of the ﬂy model
inwhich Ab expression only occurred on oral dosing with RU486. In
the ﬁrst set of experiments (Fig. 2A), when Ab was expressed in
15 days intervals, we found that the earliest, days 1e15, exposure
window had only minimal consequences for the ﬂies; exposure to
Ab later in life resulted in a reduction in the median survival. In the
Fig. 9. Relative metabolite changes in Drosophila head and body samples with age. The panels present fold changes in concentration relative to 1-day-old 51D control ﬂies for
selected metabolites from body (panels AeF) and head (panels GeL) samples. Concentrations for gluconic acid (A, G), histidine (B, H), and maltose (C, I) are shown for both body and
head samples. Phosphocholine (D), an unidentiﬁed methyl group (E) and unidentiﬁed aromatic compound 2 (F) are shown for body samples, whereas lactate (J), xanthurenic acid
(K), and unidentiﬁed aromatic compound 1 (L) are shown for the head samples. The individual panels display values for all replicate samples for each age and genotype. Note that for
metabolites that have low concentrations in 1-day-old 51D control ﬂies (A, EeG, KeL), the relative increase can be underestimated because of contributions from overlapping
stronger signals.
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those in which Ab was expressed early (days 1e15), late (after day
15), continuously, or never. In this study, the lifespan of ﬂies
expressing Ab only after day 15 was essentially identical to those
where Ab expression was continuous. This in turn indicates that
there was little or no contribution of early Ab to the accumulated
deﬁcits later in life. To quantify the early and late contributions of
Ab expression to mortality, we plotted and compared the 4 mor-
tality trajectories (Fig. 2C). Remarkably, the gradient of the mor-
tality trajectories was determined by whether Abwas induced after
day 15, whereas early Ab expression resulted in a displacement
along the y-axis. Assuming that this displacement accumulated
steadily over the ﬁrst 15 days of life, we can estimate that older ﬂies
were 50% more susceptible to the lethal effects of the peptide, as
compared with the young population.
The differential effects of early and late Ab exposure might be
because of the way in which the organism handles the peptide at
different stages of its life. To investigate this possibility, we collected
ﬂies from the 4 cohorts at various ages and made both total- and
SDS-soluble Ab extracts. We observed that early expression of Ab
led to the accumulation of soluble material, but this was quickly
cleared, provided that expression was stopped at day 15 (Fig. 3A
and Supplementary Fig. 7A); otherwise, continued expression
resulted in the conversion of this soluble peptide into insoluble
isoforms (Fig. 3B and Supplementary Fig. 7B). It is remarkable that
soluble Ab is lower in ﬂies following induction at day 15 as
compared with continuous expression. That these 2 groups of ﬂies
have identical longevity suggests that toxicity is generated by after
day 15 insoluble peptide that is elevated similarly in both. This
observation stands in contrast to the current consensus in the
literaturewhere small, SDS-soluble, oligomers (dimers) are thoughtto be the primary toxic Ab species (Shankar et al., 2008). Overall,
our ﬁndings support the study by Rogers et al (Rogers et al., 2012)
who observed acute Ab expression in older (>20 days) ﬂies results
in higher levels of Ab and stronger reductions in longevity as
compared with Ab expression in younger ﬂies.
These data give us a picture of an organism that is robust in
youth, but having passed an age threshold, becomes sensitive to Ab
toxicity; thereafter, the peptide seems to accelerate the aging pro-
cess. Before this threshold age, the peptide appears to be held in a
less-toxic, soluble, and labile conformation, and its subsequent
conversion into insoluble material is associated with increasing
mortality. There is evidence, particularly in C. elegans, that the stress
placed on cells by such protein misfolding and deposition may
unmask temperature-sensitive phenotypes. Speciﬁcally age and
poly-glutamine expression sensitise the worm to the paralysis
caused by a temperature-sensitive dynamin mutation (Ben-Zvi
et al., 2009; Gidalevitz et al., 2006). Similar age-related protein
destabilization is also seen in Drosophila, and so we investigated its
role in the increased Ab-related sensitivity seen in older ﬂies
(Demontis et al., 2013). Using a novel temperature titration assay in
shibireTS2 ﬂies that, like the worm carry a temperature-sensitive
dynamin mutation (Chen et al., 1992; van der Bliek and
Meyerowitz, 1991), we found that locomotion slowed progres-
sively with increasing ambient temperature (Fig. 4). As predicted by
the proteostatic hypothesis, we found that older shibire ﬂies
became paralyzed at progressively lower temperatures. However,
under conditions where Arctic Ab42 accumulated in brain sections,
with lethal consequences (Supplementary Figs. 4 and 6); there was
no effect on the paralysis titration proﬁles (compare Fig. 4, panels A
with C). Assuming that the increased sensitivity of older shibire ﬂies
to heat-induced paralysis is reporting proteostatic decompensation,
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tive proteome-destabilizing factor.
Although Ab appears not to exert its aging effects by accelerating
a proteostatic collapse, our previous work has indicated that
metabolic consequences, not least oxidative stress, may be
responsible (Rival et al., 2009). To test whether we could detect an
early metabolic effect of Ab expression, we challenged ﬂies with
hydrogen peroxide in their food. In particular, we tested how ﬂies,
expressing Ab40 or Ab42, responded to oxidative stress before and
after the day 15 threshold. We observed an age-related increase in
hydrogen peroxide sensitivity in control and Ab40 expressing ﬂies.
Remarkably, we also found that day 2 ﬂies, expressing the Ab42
isoform, were already as sensitive to oxidative stress as day 20 ﬂies.
These data are compatible with there being a biochemical signal,
rather than a proteostatic defect, underpinning the transition from
the robustness of youth to the fragility of older age. Surprisingly, we
also noticed that 20-day-old control ﬂies weremore sensitive to the
peroxide challenge than Ab40 expressing ﬂies. Although the precise
mechanisms for this need further investigation, we speculate that
the presence of nontoxic Ab40 can act as a mild stressor and lead to
an increase in reactive oxygen species defence without triggering
Ab toxicity.
To systematically investigate the metabolic changes associated
with Ab expression, we made extracts of water-soluble bio-
chemicals from ﬂy tissues at various ages and subjected them to
analysis by NMR spectroscopy. The ﬂies were separated into heads,
to allow us to measure the local consequences of Ab production,
and bodies, where systemic metabolic changes could be assessed.
Initially, the NMR spectra were subjected to PCA to provide an
unbiased summary of the Ab- and age-dependent metabolic
changes (Fig. 6). We ﬁrst noted an age-related trajectory that was
largely similar for all genotypes. The metabolome of all Drosophila
variants changed most rapidly during the ﬁrst 8 days of life,
whereas there was a smaller rate of change in the older ﬂies.
However, the expression of any Ab isoform, whether it is Ab40, Ab42,
or Arctic Ab42, resulted in a displacement in the age-related tra-
jectories away from the control population. This displacement was
already evident from the earliest time points, indicating that the
expression of Ab results in early metabolic alterations.
Our next OPLS-DA model helped us visualize the differences
between 3 groups of ﬂies: (1) healthy controls, (2) asymptomatic
ﬂies expressing the aggregation-prone Ab42, and (3) ﬂies expressing
the lethal Arctic Ab42 (Fig. 7). We observed that the systemic
metabolome of the oldest control and Ab42 expressing ﬂies changed
so that it became more similar to, albeit younger, Ab42 Arctic ﬂies,
indicating a related systematic response between aging and Ab
toxicity. Likewise, Ab42 Arctic ﬂies appeared older than other ge-
notypes in an OPLS model of age in the systemic metabolome
(Supplementary Fig. 5).
We then identiﬁed a set of metabolites that could be used to
differentiate control ﬂies from those expressing any isoform of Ab
(Fig. 8 panels A and B), and a distinct set (Fig. 8 panels C and D) that
could differentiate ﬂies expressing Arctic Ab42, from ﬂies with a
normal life-expectancy (controls, Ab40 and Ab42). These 2 orthog-
onal sets of metabolites provided a 2-way differentiation in a ner-
vous environment from heads and for the systemic metabolites
from the bodies.
Remarkably, all Ab-expressing ﬂies exhibited a shift in carbo-
hydrate metabolism, with maltose, a dietary glucose disaccharide,
increasing 3-to 4-fold in both head and body extracts (Fig. 9 panels
C and I). Similar increases were observed in Drosophila in response
to both acute stress and artiﬁcial selection for stress resistance
(Malmendal et al., 2013; Overgaard et al., 2007); interestingly,
maltose has been suggested to have a chaperone-like function for
proteins and membranes (Kaplan and Guy, 2004; Pereira andHunenberger, 2006). Levels of xanthurenic acid were raised in
ﬂies expressing all 3 Ab isoforms (Fig. 9K) indicating potential
involvement of the kynurenine pathway that generates vitamin B3
from tryptophan, using vitamin B6 as a cofactor. Low levels of
vitamin B6 result in raised proximal intermediates that are con-
verted, by oxidation, to xanthurenic acid. It is notable that such
intermediates as kynurenine and 3-OH-kynurenine are raised, as a
ratio to tryptophan, in patients with AD (Gulaj et al., 2010;
Schwarz et al., 2013). Furthermore, several studies have also
shown that vitamin B therapy is protective in AD (Douaud et al.,
2013).
The metabolites that separate Arctic Ab42 ﬂies from the other
isoforms can be divided into those that are deviating from day one
and those that mainly change after day 14 and deviate further with
age. The unidentiﬁed, potentially hydroxylated, carboxylated, or
chlorinated aromatic compounds appeared in both heads and
bodies of Arctic Ab42 ﬂies, already from day 1 (Fig. 9 panels E, F, and
L). If these are end products of oxidative stress it provides an
interesting perspective on the H2O2 challenge experiments, since it
indicates that the Ab-induced chemical stress is taking place
already from day 1 and with rather constant intensity. Decreased
AXP levels in the bodies (Fig. 8C) follow a similar pattern and
indicate that there is a reduction in adenosine triphosphate pro-
duction, and a resulting loss in total adenosine phosphate, through
deamidation of adenosine monophosphate to inosine mono-
phosphate, already from day 1.
In contrast, gluconic acid was increased from around day 8 in
bodies and day 14 in heads (Fig. 9 panels A and G). Accumulation of
this metabolite was induced by severe oxidative stress and
apoptosis in breast cancer cells (Morvan, 2013), and a 100 fold in-
crease was induced by oxidative stress in Arabidopsis (Chaouch
et al., 2012; Han et al., 2013). An increase in gluconic acid may
either reﬂect oxidation of glucose or enhanced production of 6-
phosphogluconate through the oxidative pentose phosphate
pathway. When yeast is submitted to oxidative stress, part of the
central carbohydrate metabolism is rerouted away from respiratory
pathways into the oxidative pentose phosphate pathway to provide
reducing equivalents to support antioxidant metabolism (Godon
et al., 1998). The results are consistent with the view that the
tricarboxylic acid cycle is impacted signiﬁcantly by Ab, resulting in
oxidative stress (Baxter et al., 2007; Noctor et al., 2015).
Histidine is increased from day 1 in heads and from day 8 in
bodies, and the increase is accelerated between days 14 and 26
(Fig. 9 panels B and H). This amino acid is a precursor for histamine
and carnosine biosynthesis and a powerful antioxidant and anti-
inﬂammatory factor (Peterson et al., 1998). Low levels of histidine
have been associated with inﬂammation and oxidative stress in
humans (Niu et al., 2012; Watanabe et al., 2008). Moreover, histi-
dine is increased in urine from patients with Parkinson’s disease
(Luan et al., 2015).
Ab-expressing ﬂies had lower systemic levels of phosphocholine
(Fig. 9D), reﬂecting similar reductions, in most brain regions, in a
murine model of AD (Salek et al., 2010). By contrast, phosphocho-
line levels were higher in blood from patients with the earliest
stages of AD (Mapstone et al., 2014).
Although still much higher than in control ﬂies, maltose de-
creases to levels below Ab40 and Ab42 in middle-aged Ab42 Arctic
ﬂies (Fig. 9 panels C and I). Abnormalities in sugar metabolism
combined with raised lactate levels in ﬂy heads are indicative of
defects in aerobic respiration, and this is further supported by the
reductions in AXP levels in the body extracts. Similarly, lactate is
increased in brains of mice that model AD (Salek et al., 2010).
The changes in histidine (Fig. 9 panels B and H) and gluconic acid
(Fig. 9 panels A and G) levels are remarkable, because they occur
just at the time when the ﬂies were undergoing the transition from
Fig. 10. A timecourse of A expression alongside metabolomic correlates of experimental phentoypes. The timecourse of Ab expression (A) is plotted alongside consequent
experimental phenotypes (BeE). The increasing sensitivity of the ﬂies to Ab toxicity at day 15 (B) was closely correlated in time with sensitivity to an oxidative stressor in control
ﬂies (C, control). The presence of Ab brings forward the onset of oxidative sensitivity (C, Ab42). Thermal destabilization of dynamin, as a marker of proteostasis, occurs gradually with
age across this timecourse (D). Ab expression did not further functionally destabilize dynamin (E). Metabolic markers for AeD are presented (right column, [ ¼ increase,
Y ¼ decrease). Metabolites that did not change with time (E) were not considered informative. Abbreviation: Ab, amyloid beta.
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biomarkers of the metabolic fragility that accompanies the lethal
effects of Ab accumulation. The aromatic oxidation products (Fig. 9
panels E, F, and L) and the changes in AXP, on the other hand, appear
already from day 1 in agreement with the increase susceptibility to
H2O2 challenge already at an early age.
The metabolite changes observed here (Fig. 10) only show a
limited overlap with those detected in mouse (Salek et al., 2010)
and man (Trushina and Mielke, 2013). There are multiple expla-
nations: we use whole body parts rather than organs or body ﬂuids,
we separate effects of Ab expression and Ab toxicity, and we do of
course use ﬂies, and as it seems, the dominating effects here are
those of decreased oxidative phosphorylation and increased
oxidative stress.
In conclusion, whereas Ab aggregation accelerates mortality in
older ﬂies, it does not seem to do this by exacerbating proteostatic
collapse. Rather, the ﬂies exhibit earlier oxidative stress, in response
to Ab expression that closely mirrors increases in mortality. The
effects of this stress become obvious at older ages, inducing changes
both in the lethality and the metabolomic proﬁle.
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